Marc Verstraete

Coronary Thrombolysis with Tissue-Type Plasminogen Activator in Patients with Evolving Myocardial Infarction

Frans Van de Werf, Philip A. Ludbrook, Steven R. Bergmann et al. · New England Journal of Medicine · 1984 · 361 citations

Medicine, Cardiology, Pharmacology +13

Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: A European multicenter double-blind trial

Guy Meyer, Hervé Sors, B Charbonnier et al. · Journal of the American College of Cardiology · 1992 · 237 citations

Medicine, Internal Medicine, Surgery +13

The physiological inhibitors of blood coagulation and fibrinolysis

Marc Verstraete, R. Verhaeghe · Advances in Contraception · 1991 · 173 citations

Medicine, Biochemistry, Physiology +14

Thrombolysis in the management of lower limb peripheral arterial occlusion - a consensus document

Marc Verstraete · Ghent University Academic Bibliography (Ghent University) · 1997 · 162 citations

Medicine, Orthopedic Surgery, Surgery +13

Benefit of Thrombolytic Therapy Is Sustained Throughout Five Years and Is Related to TIMI Perfusion Grade 3 But Not Grade 2 Flow at Discharge

Timo Lenderink, Maarten L. Simoons, Gerrit‐Anne van Es et al. · Circulation · 1995 · 120 citations · Full text

Medicine, Cardiology, Clinical Cardiology +13